Cencora’s (COR) Sector Perform Rating Reiterated at Royal Bank Of Canada

11 Sep 2026, 05:24 by Tristan Rich · The Markets Daily

Royal Bank Of Canada reiterated their sector perform rating on shares of Cencora (NYSE:COR – Free Report) in a research report report published on Tuesday, MarketBeat Ratings reports. Royal Bank Of Canada currently has a $330.00 price target on the stock.

Several other analysts also recently issued reports on COR. Morgan Stanley lifted their price target on shares of Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Wall Street Zen upgraded shares of Cencora from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. UBS Group raised their price objective on shares of Cencora from $412.00 to $430.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Bank of America lifted their price objective on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cencora from $382.00 to $390.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cencora currently has an average rating of “Moderate Buy” and a consensus price target of $370.85.

Get Our Latest Stock Analysis on COR

Cencora Stock Down 0.6%

COR stock opened at $321.34 on Tuesday. The stock’s 50 day simple moving average is $315.32 and its 200 day simple moving average is $308.53. The company has a market cap of $61.32 billion, a P/E ratio of 23.87, a price-to-earnings-growth ratio of 1.83 and a beta of 0.57. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93. Cencora has a fifty-two week low of $244.82 and a fifty-two week high of $377.54.

Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The firm had revenue of $84.75 billion during the quarter, compared to analysts’ expectations of $84.31 billion. During the same quarter last year, the firm posted $4.00 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, research analysts expect that Cencora will post 17.87 earnings per share for the current fiscal year.

Cencora announced that its board has approved a share repurchase plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its stock is undervalued.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s dividend payout ratio is presently 17.83%.

Insider Buying and Selling at Cencora

In other news, Director Lauren M. Tyler acquired 550 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director directly owned 4,359 shares of the company’s stock, valued at $1,177,932.57. The trade was a 14.44% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elizabeth Campbell sold 11,300 shares of Cencora stock in a transaction on Monday, August 24th. The stock was sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the transaction, the executive vice president directly owned 19,455 shares in the company, valued at $6,305,754.60. This represents a 36.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.38% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Kemnay Advisory Services Inc. bought a new position in shares of Cencora during the 4th quarter worth approximately $25,000. Elyxium Wealth LLC purchased a new position in shares of Cencora in the 4th quarter worth approximately $27,000. Elevation Wealth Partners LLC grew its holdings in shares of Cencora by 506.2% in the second quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after acquiring an additional 81 shares in the last quarter. Bell Investment Advisors Inc purchased a new stake in shares of Cencora during the second quarter valued at approximately $28,000. Finally, Caitlin John LLC purchased a new stake in shares of Cencora during the second quarter valued at approximately $28,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

About Cencora

(Get Free Report)

Cencora, Inc (NYSE:COR) is a global healthcare company that provides pharmaceutical sourcing, distribution and related services. The company connects biopharmaceutical manufacturers with pharmacies, hospitals, health systems, physician practices and other healthcare providers, helping move prescription medicines and healthcare products through the supply chain.